None listed
Conditions
Brief summary
A parallel double blind randomised placebo-controlled study was conducted to assess the effects of a Chinese herbal medicine, the Dantonic Pill, on circulating adhesion molecules in participants with mild-moderate hypercholesterolemia.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Healthy individuals aged 18 years and over with a total plasma cholesterol of 5.0 mmol/L or above, triglyceride level of greater than 2 mmol/L or high density lipoprotein (HDL) cholesterol level of less than 1.0 mmol/L.
Exclusion criteria
Exclusion criteria included plasma triglyceride levels over 10 mmol/L, established heart disease, other serious medical or psychological conditions, pregnancy, current use of vasoactive medications, warfarin, and postmenopausal hormone therapy.